Idifarma provides contract development and manufacturing services for niche and highly potent generic or innovative drugs

Pharmaceutical R&D and Manufacturing Services

Idifarma is an independent, privately-owned pharmaceutical CDMO based in Spain and specializing in highly potent drugs.

With an experienced staff of 100+ people and over 100 international clients, Idifarma provides a full range of services covering most of the lifecycle of any pharmaceutical product from first pre-formulation trials to commercial manufacturing: drug formulation, development and validation of analytical methods, quality control and batch release in the EU, stability studies, regulatory affairs, GMP contract manufacturing and packaging for clinical or commercial use.

Its state-of-the-art facility features a purpose-built high containment plant for GMP manufacturing of oral solid dosage forms, for both highly potent and non-potent drugs.

Idifarma’s expertise, capabilities and proven track record make it the perfect partner for the development of your projects.


Idifarma at BioSpain 2018

Idifarma has been present at BioSpain 2018 congress with a positive evaluation and interesting opportunities


We are proud to announce that Idifarma has been successfully inspected by EU-GMP the Spanish authorities!
Read all the information here,

Niche CDMO confirms spray drying for highly potent drugs @Idifarma |

New Niro Mobile Minor equipment @GEAPharma installed at @Idifarma is now in operation #HAPIs #cleanroom

La navarra @Idifarma es una de las tres únicas empresas en el mundo que ofrecen este tipo de tecnología GMP "spray drying" #EmpresaApoyadaPorSodena

We are proud to confirm GMP spray drying technologies for higlhy potent drugs up to Category 4 OEL/OEB is now operational!
Read all the information here,

Load More...

Do you want to receive the latest news from Idifarma?

Utilizamos cookies propias y de terceros para realizar el análisis de la navegación de los usuarios y mejorar nuestros servicios. Si continúa navegando, consideramos que acepta su uso. Puede obtener más información, o bien conocer cómo cambiar la configuración pulse aquí ACEPTAR

Aviso de cookies